In silico identification of deleterious NT5C2 and PRPS1 mutations driving thiopurine resistance in relapsed acute lymphoblastic leukemia.
第一作者:
Ramita,Sharma
第一单位:
Research and Development, Indo-American Cancer Research Foundation, Basavatarakam Indo-American Cancer Hospital and Research Institute, Banjara Hills, Hyderabad, Telangana 500034, India; School of Bioengineering and Biosciences, Lovely Professional University, Punjab, India.
作者:
医学主题词
人类(Humans);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);抗药性, 肿瘤(Drug Resistance, Neoplasm);5'-核苷酸酶(5'-Nucleotidase);突变(Mutation);计算机模拟(Computer Simulation)
DOI
10.1016/j.cancergen.2026.01.001
PMID
41518974
发布时间
2026-03-15
- 浏览0
Cancer genetics
8-12页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



